In stroke and ischemia models, increased expressions of CD36 were demonstrated mainly by microglial cells in a PPARγ-dependent manner, which was associated with the resolution of neuroinflammation through phagocytosis (Ballesteros et al., 2014; Zhao et al., 2020). Here, CD36 is linked to stroke disorder.